 to the editor re new drug regimen greatly cuts risk of recurring breast cancer front page oct 10 we have no idea what the long term effects of letrozole might be and the risk of osteoporosis was considerably higher for women on letrozole than for the placebo group the medical profession 's tendency to shoot first and ask questions later on drug protocols is fraught with peril as many learned from the controversy over hormone replacement therapy the long term effects of cancer prevention drugs take decades to uncover barbara a brenner executive director breast cancer action san francisco oct 14 2003

